✦ LIBER ✦

Lymphatic transport of cholesterol in normocholesterolemic rats treated with pravastatin, an inhibitor of HMG-CoA reductase

✍ Scribed by Masanobu Sakono; Toko Ibi; Koji Nagao; Ikuo Ikeda; Kyosuke Yamamoto; Katsumi Imaizumi

Book ID: 118326373
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 647 KB
Volume: 124
Category: Article
ISSN: 0021-9150
DOI: 10.1016/0021-9150(96)05826-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction of myocardial infarct size by

Reduction of myocardial infarct size by a HMG CoA-reductase inhibitor in normocholesterolemic rats

✍ Sebastian Wolfrum; Michael Grimm; Marc Heidbreder; Andreas Dendorter; Hugo A. Ka 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Treating hypercholesterolaemia with HMG

Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin

✍ Lintott, C. J. ;Sutherland, W. H. F. ;Scott, R. S. ;Bremer, J. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

The effects of pravastatin, an HMG-CoA r

The effects of pravastatin, an HMG-CoA reductase inhibitor, on cell viability and dna production of rat hepatocytes

✍ Takeaki Satoh; Hidehiko Isobe; Kusuo Ayukawa; Hironori Sakai; Hajime Nawata 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 459 KB

Effects of simvastatin, an HMG-CoA reduc

Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia

✍ Jonathan Isaacsohn; Donald Hunninghake; Helmut Schrott; Carlos A. Dujovne; Rober 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Effect of pravastatin, a HMG CoA reducta

Effect of pravastatin, a HMG CoA reductase inhibitor, on blood lipids and aortic lipidosis in cholesterol-fed White Carneau pigeons

✍ Hadjiisky, Peter; Hermier, Dominique; Truffert, Jacqueline; De Gennes, Jean-Luc; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 745 KB

Disposition of fluvastatin, an inhibitor

Disposition of fluvastatin, an inhibitor of HMG-CoA reductase, in mouse, rat, dog, and monkey

✍ F. L. S. Tse; H. T. Smith; F. H. Ballard; J. Nicoletti 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

The physiological disposition offluvastatin, a potent inhibitor of hydroxymethylglutaryl-CoA reductase and thus cholesterol synthesis, has been studied in the mouse, rat, dog, and monkey using 14C-or 3H-labeled drug. Oral doses of fluvastatin were absorbed at a moderate to rapid rate. The extent of